Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials
In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened
Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs
GM To Offer Three Awards of $1000,000 Each To Cancer Investigators
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line









